视网膜神经节细胞-内丛状层厚度相关血浆代谢谱与死亡及常见疾病的关系分析
该研究基于UK Biobank 2006至2010年入组、前瞻随访12.3(0.8)年的93838名社区参与者(女性51182人,54.5%;平均年龄56.7(8.1)岁),系统分析循环血浆代谢物以识别与GCIPLT相关的代谢谱,并分析其与6种常见疾病发病及死亡的关联,另用广州糖尿病眼研究(GDES)队列采用不同代谢组学方法验证。249项代谢指标中37项与GCIPLT独立相关(8项正相关、29项负相关),这些代谢谱在临床指标基础上显著改善2型糖尿病、心肌梗死、心力衰竭、卒中、全因死亡和心血管死亡的判别(各P<.001),并在GDES队列中进一步证实其心血管疾病风险分层潜力。作者认为,纳入这些代谢谱信息可能有助于个体化风险分层,但本文未给出急诊/ICU床旁可直接使用的阈值或干预方案。
要点
- 在93838名UK Biobank社区参与者中,249项血浆代谢指标有37项与GCIPLT独立相关(8项正相关、29项负相关),多数同时与未来死亡和常见疾病发生率相关。
- 加入GCIPLT相关代谢谱后,2型糖尿病判别C统计量由仅临床指标的0.803(95%CI 0.792-0.814)升至0.862(95%CI 0.852-0.872),P<.001。
- 心肌梗死判别C统计量由0.768(95%CI 0.751-0.786)升至0.792(95%CI 0.775-0.808),P<.001;心力衰竭由0.790(95%CI 0.773-0.807)升至0.803(95%CI 0.786-0.820),P<.001。
- 卒中判别C统计量由0.719(95%CI 0.693-0.745)升至0.739(95%CI 0.714-0.764),P<.001;全因死亡由0.724(95%CI 0.711-0.738)升至0.747(95%CI 0.734-0.760),P<.001;心血管死亡由0.763(95%CI 0.739-0.788)升至0.790(95%CI 0.767-0.812),P<.001。
- 作者认为,纳入GCIPLT相关代谢谱信息可能有助于上述健康结局的个体化风险分层,该风险分层潜力在GDES队列中以不同代谢组学方法得到进一步证实。
适用人群与场景
- UK Biobank社区参与者93838人,2006至2010年入组,女性51182人(54.5%),平均年龄56.7(8.1)岁,平均随访12.3(0.8)年。
- 验证队列为广州糖尿病眼研究(GDES)参与者,接受光学相干断层扫描和代谢组学分析。
研究设计与关键结果
- 研究类型为前瞻性队列研究,UK Biobank纳入93838名社区参与者,另以GDES队列进行验证;主要分析循环血浆代谢物与GCIPLT的独立关联及其与死亡和6种常见疾病发病的关联。
- 249项代谢指标中37项与GCIPLT独立相关,包括8项正相关和29项负相关,多数同时与未来死亡和常见疾病发生率相关。
- 加入GCIPLT相关代谢谱后,2型糖尿病判别C统计量0.862(95%CI 0.852-0.872) vs 仅临床指标0.803(95%CI 0.792-0.814),P<.001。
- 心肌梗死判别C统计量0.792(95%CI 0.775-0.808) vs 0.768(95%CI 0.751-0.786),P<.001;心力衰竭0.803(95%CI 0.786-0.820) vs 0.790(95%CI 0.773-0.807),P<.001。
- 卒中判别C统计量0.739(95%CI 0.714-0.764) vs 0.719(95%CI 0.693-0.745),P<.001;全因死亡0.747(95%CI 0.734-0.760) vs 0.724(95%CI 0.711-0.738),P<.001;心血管死亡0.790(95%CI 0.767-0.812) vs 0.763(95%CI 0.739-0.788),P<.001。
- GCIPLT相关代谢谱对心血管疾病风险分层的潜力在GDES队列中使用不同代谢组学方法得到进一步证实。
证据类型、等级与局限
- 证据类型:前瞻性队列研究(UK Biobank)加外部队列验证(GDES)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,纳入GCIPLT相关代谢谱信息可能有助于2型糖尿病、心肌梗死、心力衰竭、卒中、全因死亡和心血管死亡的个体化风险分层。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The neural retina is considered a unique window to systemic health, but its biological link with systemic health remains unknown.
OBJECTIVE: To investigate the independent associations of retinal ganglion cell-inner plexiform layer thickness (GCIPLT) metabolic profiles with rates of mortality and morbidity of common diseases.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study evaluated UK Biobank participants enrolled between 2006 and 2010, and prospectively followed them up for multidisease diagnosis and mortality. Additional participants from the Guangzhou Diabetes Eye Study (GDES) underwent optical coherence tomography scanning and metabolomic profiling and were included for validation.
MAIN OUTCOMES AND MEASURES: Systematic analysis of circulating plasma metabolites to identify GCIPLT metabolic profiles; prospective associations of these profiles with mortality and morbidity of 6 common diseases with their incremental discriminative value and clinical utility.
RESULTS: Among 93 838 community-based participants (51 182 [54.5%] women), the mean (SD) age was 56.7 (8.1) years and mean (SD) follow-up was 12.3 (0.8) years. Of 249 metabolic metrics, 37 were independently associated with GCIPLT, including 8 positive and 29 negative associations, and most were associated with the rates of future mortality and common diseases. These metabolic profiles significantly improved the models for discriminating type 2 diabetes over clinical indicators (C statistic: 0.862; 95% CI, 0.852-0.872 vs clinical indicators only, 0.803; 95% CI, 0.792-0.814; P < .001), myocardial infarction (0.792; 95% CI, 0.775-0.808 vs 0.768; 95% CI, 0.751-0.786; P < .001), heart failure (0.803; 95% CI, 0.786-0.820 vs 0.790; 95% CI, 0.773-0.807; P < .001), stroke (0.739; 95% CI, 0.714-0.764 vs 0.719; 95% CI, 0.693-0.745; P < .001), all-cause mortality (0.747; 95% CI, 0.734-0.760 vs 0.724; 95% CI, 0.711-0.738; P < .001), and cardiovascular disease mortality (0.790; 95% CI, 0.767-0.812 vs 0.763; 95% CI, 0.739-0.788; P < .001). Additionally, the potential of GCIPLT metabolic profiles for risk stratification of cardiovascular diseases were further confirmed in the GDES cohort using a different metabolomic approach.
CONCLUSIONS AND RELEVANCE: In this prospective study of multinational participants, GCIPLT-associated metabolites demonstrated the potential to inform mortality and morbidity risks. Incorporating information on these profiles may facilitate individualized risk stratification for these health outcomes.
参考来源
- Yang S, Zhu Z, Yuan Y, et al. Analysis of Plasma Metabolic Profile on Ganglion Cell-Inner Plexiform Layer Thickness With Mortality and Common Diseases. JAMA Netw Open. 2023. PMID: 37191963. doi:10.1001/jamanetworkopen.2023.13220
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。